Press Releases by Category Health & Medicine
ATTR Amyloidosis Clinical Trials Analysis 2025: RNA-silencing, TTR Stabilizers, …
DelveInsight's "ATTR Amyloidosis - Clinical Trials Analysis, 2025" describes a crowded, fast-moving development landscape focused on two complementary goals: (1) suppress hepatic TTR production or stabilize circulating TTR to stop further amyloid deposition, and (2) reverse organ dysfunction (cardiac and neuropathic) and improve survival, functional capacity, and quality of life. Ongoing programs span TTR stabilizers, RNA-silencing/ASO agents for transthyretin reduction, repeat-dose oligonucleotides, and emerging in-vivo gene-editing candidates that could offer…
Teleradiology Services Market Forecasted to Reach USD 31.5 Billion by 2034, Key …
The healthcare industry is undergoing a digital revolution, and among the most transformative innovations is teleradiology-the remote transmission and interpretation of medical images. Teleradiology services are bridging the gap between patient needs and specialist availability, ensuring timely diagnosis, particularly in underserved and rural areas. As global healthcare systems strive for efficiency, accuracy, and accessibility, the teleradiology services market is poised for exponential growth. With increasing adoption of advanced imaging technologies,…
Alcohol Use Disorder Clinical Trials Analysis 2025: Psychedelic-Assisted Therapy …
DelveInsight's "Alcohol Use Disorder - Clinical Trials Analysis, 2025" describes a broad, rapidly evolving trial landscape that pairs novel pharmacology with behavioral interventions to reduce heavy drinking, prevent relapse, and improve functioning. Trials now prioritize both objective drinking outcomes (percent heavy drinking days, abstinence, biomarker-verified consumption) and patient-centered endpoints (craving, quality of life, treatment retention).
Late-stage and registration-enabling programs span three complementary strategies: psychedelic-assisted psychotherapy (psilocybin) for relapse prevention and…
Blockbuster Drugs Market Growth Through Innovation, Biologics, and Specialty The …
Introduction
Blockbuster drugs-defined as pharmaceutical products generating over USD 1 billion in annual revenue-have long been the backbone of the pharmaceutical industry. These drugs transform healthcare by addressing widespread chronic diseases, including cardiovascular disorders, cancer, diabetes, autoimmune conditions, and infectious diseases.
While the traditional blockbuster model has faced challenges from patent expirations and generic competition, innovation in biologics, biosimilars, cell and gene therapies, and specialty medicines is sustaining long-term growth. The rising…
mRNA Market Forecasted to Reach USD 128.6 Billion by 2034, Key Players: Moderna …
Messenger RNA (mRNA) has emerged as one of the most transformative technologies in modern medicine. Once considered a niche research tool, mRNA technology has been propelled into the global spotlight by the success of COVID-19 vaccines from Moderna and Pfizer-BioNTech. Beyond infectious disease prevention, mRNA holds tremendous promise in oncology, rare genetic disorders, and protein replacement therapies. Its ability to deliver precise instructions for protein synthesis has unlocked new possibilities…
Friedreich's Ataxia Market to Reach USD 3.04 Billion by 2034, Growing at 10.6% C …
Introduction
Friedreich's ataxia (FA) is a rare, inherited neurodegenerative disease caused by mutations in the FXN gene, leading to progressive damage to the nervous system and impaired muscle coordination. The disease typically begins in childhood or adolescence, causing gait instability, speech difficulties, heart complications, and, eventually, loss of mobility.
For decades, treatment has been limited to symptom management, but advancements in gene therapy, protein replacement therapies, and small-molecule drugs are reshaping the…
Ocular Drug Delivery Devices Market Forecasted to Reach USD 27.4 Billion by 2034 …
The human eye is one of the most complex and delicate organs, requiring precise and effective drug delivery methods. Traditional eye drops and systemic drugs often face challenges such as low bioavailability, poor patient compliance, and limited therapeutic effect. This has created strong demand for ocular drug delivery devices, which ensure targeted, sustained, and effective delivery of medication directly to ocular tissues. With the rising prevalence of ophthalmic diseases such…
Heart Failure Clinical Trials Analysis 2025: SGLT2 Inhibitors, Novel Inotropes, …
DelveInsight's "Heart Failure - Clinical Trials Analysis, 2025" outlines a dynamic development landscape targeting the multifactorial pathophysiology of heart failure (HF), including myocardial dysfunction, fluid overload, and systemic inflammation. Trials increasingly assess both hard clinical endpoints (mortality, hospitalization) and patient-centered measures (exercise capacity, quality of life, functional status) to capture meaningful benefit across HF subtypes - HFrEF, HFpEF, and acute decompensated HF.
Late-stage and registration-enabling programs include SGLT2 inhibitors for cardiovascular…
Bevacizumab Biosimilars Market Forecasted to Reach USD 9.8 Billion by 2034, Key …
Biosimilars are reshaping the pharmaceutical industry by offering cost-effective alternatives to biologic therapies. Among these, Bevacizumab biosimilars have become a critical focus due to their role in treating cancers such as colorectal, lung, ovarian, and glioblastomas. Bevacizumab, originally commercialized under the brand Avastin by Genentech/Roche, is a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby restricting tumor angiogenesis. With the original patent expiries, multiple biosimilars have entered the…
Self-amplified tumor-targeting therapy using vascular-disrupting chemicals
Introduction
Vascular Disrupting Agents (VDAs) represent an innovative class of oncology drugs designed to selectively damage the established blood vessels within tumors, leading to rapid ischemia and cancer cell death. Unlike anti-angiogenic agents that inhibit the formation of new blood vessels, VDAs target existing tumor vasculature, offering a complementary approach to cancer treatment.
With cancer incidence rising worldwide and limitations of conventional chemotherapy and radiation persisting, VDAs are gaining attention as part…
Biospecimen Procurement Market Forecasted to Reach USD 120.8 Billion by 2034, Ke …
The rise of precision medicine, biomarker discovery, and advanced diagnostics has made biospecimen procurement a cornerstone of modern healthcare and life sciences research. Biospecimens-including blood, tissue, plasma, urine, and other human-derived samples-are critical for drug discovery, translational research, and clinical trials. Pharmaceutical companies, academic institutions, and diagnostic firms rely on high-quality biospecimens to accelerate product development and regulatory approvals.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72675
With growing global…
TIL Therapy Market to Reach USD 2.14 Billion by 2034, Growing at 17.8% CAGR
Introduction
Tumor-Infiltrating Lymphocyte (TIL) therapy represents one of the most promising advancements in cancer immunotherapy. By harnessing and expanding a patient's own immune cells to fight tumors, TIL therapy has demonstrated strong clinical potential in treating solid tumors such as melanoma, lung cancer, and cervical cancer.
Unlike CAR-T therapies, which have shown greater success in hematological malignancies, TIL therapy is uniquely positioned for solid tumor treatment-a segment that accounts for the majority…
Market for clinical trial design is expected to grow to USD 32.4 billion by 2034 …
Clinical trials form the backbone of modern drug and device development. However, the rising complexity of diseases, patient diversity, and the demand for faster, cost-efficient approvals have transformed the way trials are designed. The clinical trial design market is witnessing a paradigm shift from traditional randomized controlled trials to more adaptive, decentralized, and patient-centric designs. These innovative models not only reduce time and cost but also improve trial efficiency and…
Cholangiosarcoma Market Rising Incidence, and Emerging Therapies
Introduction
Cholangiosarcoma, also referred to as bile duct cancer, is a rare but aggressive malignancy that originates in the biliary tract. Due to late-stage diagnosis, limited treatment options, and poor prognosis, the disease has historically posed significant clinical challenges. However, increasing awareness, improvements in diagnostic imaging, and the emergence of targeted and immunotherapies are reshaping the outlook for this market.
Growing prevalence of liver-related disorders, rising adoption of advanced imaging modalities, and…
Anaplastic Thyroid Cancer Pipeline 2025: Therapies Under Investigation, Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anaplastic Thyroid Cancer pipeline constitutes 8+ key companies continuously working towards developing 8+ Anaplastic Thyroid Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Anaplastic Thyroid Cancer Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Anaplastic Thyroid…
Neuronal Ceroid Lipofuscinosis (NCL) Market to Reach USD 1.38 Billion by 2034, G …
Introduction
Neuronal Ceroid Lipofuscinosis (NCL), commonly referred to as Batten disease, is a group of rare, inherited neurodegenerative disorders that primarily affect children. Characterized by progressive vision loss, seizures, cognitive decline, and motor dysfunction, NCLs represent one of the most devastating categories of lysosomal storage disorders.
Until recently, treatment options were limited to symptomatic care. However, with advances in gene therapy, enzyme replacement therapy (ERT), and orphan drug development, the NCL market…
Relapsed/Refractory Acute Myeloid Leukemia Pipeline 2025: MOA and ROA Insights, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Relapsed/Refractory Acute Myeloid Leukemia pipeline constitutes 50+ key companies continuously working towards developing 75+ Relapsed/Refractory Acute Myeloid Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Relapsed/Refractory Acute Myeloid Leukemia Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Primary Sclerosing Cholangitis Pipeline 2025: FDA Updates, Therapy Innovations, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Primary Sclerosing Cholangitis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Primary Sclerosing Cholangitis…
The non-infectious uveitis market is expected to reach USD 1.45 billion by 2034, …
Uveitis is an inflammation of the uveal tract of the eye, and when left untreated, it can cause severe vision impairment or blindness. Unlike infectious uveitis caused by pathogens, non-infectious uveitis (NIU) results from autoimmune disorders, systemic inflammatory diseases, or idiopathic factors. Managing NIU requires a multifaceted approach, including corticosteroids, immunosuppressive agents, and biologic therapies.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72679
With rising prevalence of autoimmune conditions such…
Cryptococcosis Market to Reach USD 9.8 Billion by 2034, Growing at 5.9% CAGR
Introduction
Cryptococcosis is a serious opportunistic fungal infection caused by Cryptococcus neoformans and Cryptococcus gattii. It primarily affects immunocompromised individuals, especially those with HIV/AIDS, organ transplant recipients, and patients undergoing immunosuppressive therapies. Despite being preventable and treatable, cryptococcosis continues to pose a significant global health burden, particularly in low- and middle-income countries where HIV prevalence is high.
Current treatment relies on antifungal agents such as amphotericin B, flucytosine, and fluconazole. However, limitations…
Medical Gas Market Forecast 2025-2033 | Future Growth, Share & Industry Insights
Global medical gas market reached US$ 18.98 billion in 2024 and is expected to reach US$ 68.31 billion by 2033, growing at a CAGR of 13.6% during the forecast period 2025-2033.
DataM Intelligence unveils its latest report on the "Medical Gas Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging…
Polymyositis Market on Track for Major Expansion by 2034, According to DelveInsi …
DelveInsight's "Polymyositis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Polymyositis, historical and forecasted epidemiology as well as the Polymyositis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Polymyositis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Polymyositis Market Forecast
https://www.delveinsight.com/sample-request/polymyositis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Polymyositis…
Key Players in the Tropomyosin Receptor Kinase (TRK) Fusion Cancer Market, Which …
Cancer research has entered a new era with the rise of precision medicine and genomic profiling. Among the most important breakthroughs is the identification of TRK (Tropomyosin Receptor Kinase) gene fusions, rare but actionable oncogenic drivers found in multiple solid tumors. These gene fusions, involving NTRK1, NTRK2, and NTRK3, lead to abnormal TRK protein signaling that fuels tumor growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72681
Targeted therapies for…
Glycan Analysis Market to Reach USD 1.36 Billion by 2034, Growing at 9.8% CAGR
Introduction
Glycan analysis is a critical tool in biotechnology and pharmaceuticals, enabling detailed study of carbohydrate structures (glycans) that play vital roles in protein folding, stability, and cell signaling. Glycans are central to understanding disease mechanisms, developing biologics, and ensuring product safety and efficacy in biopharmaceutical manufacturing.
With the rise of monoclonal antibodies, biosimilars, vaccines, and cell & gene therapies, glycan profiling has become indispensable for quality control, biomarker discovery, and therapeutic…
Alnylam and Ionis Pharmaceuticals are the leading companies in the RNA-targeted …
RNA-targeted therapeutics represent one of the most revolutionary breakthroughs in modern medicine. Unlike traditional drugs that focus primarily on proteins, these therapies act directly at the RNA level, enabling scientists to silence, replace, or modify faulty genetic instructions. This approach provides a powerful platform for treating genetic disorders, cancers, infectious diseases, and rare conditions that were previously considered untreatable.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72683
With the global…
Lipid CMO Market to Reach USD 4.9 Billion by 2034, Growing at 15.0% CAGR
Introduction
Lipids have become a critical component of modern pharmaceutical and biotechnology development, particularly as delivery systems for vaccines, nucleic acid therapies, and innovative biologics. The success of lipid nanoparticles (LNPs) in delivering mRNA COVID-19 vaccines has accelerated global demand for lipid manufacturing expertise, positioning Contract Manufacturing Organizations (CMOs) as essential partners for pharma and biotech firms.
The lipid CMO market is expanding rapidly, supported by increasing investment in gene therapies, RNA-based…
HER2 therapy market is expected to grow to $33.7 billion by 2034. Crucial Partic …
Breast cancer remains one of the most common cancers worldwide, and approximately 15-20% of breast cancers are driven by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein. This condition is more aggressive than HER2-negative cancers but has become highly treatable due to the development of targeted therapies. Beyond breast cancer, HER2 overexpression is also seen in gastric, colorectal, and lung cancers, making HER2 therapies an essential…
Amnesia Market to Reach USD 8.9 Billion by 2034, Expanding Growing at 6.6% CAGR
Introduction
Amnesia, characterized by partial or complete memory loss, can result from brain injury, stroke, dementia, psychological trauma, substance abuse, or neurodegenerative diseases such as Alzheimer's. While traditionally associated with aging, amnesia is increasingly recognized across all age groups due to traumatic brain injuries, mental health disorders, and substance-related complications.
Growing awareness of neurological health, advances in neuroimaging, and the rise of cognitive rehabilitation therapies are driving innovation in this space. Pharmaceutical…
Pediatric Brain Tumours Market is expected to reach USD 4.8 billion by 2034, wit …
Brain tumours are among the most common solid tumours in children and represent a significant cause of cancer-related mortality in pediatric populations. Conditions such as medulloblastoma, gliomas, ependymomas, and astrocytomas account for the majority of cases. Treatment strategies include surgery, chemotherapy, radiotherapy, and increasingly, targeted therapies and immunotherapies designed to minimize long-term side effects.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72687
Advancements in genomic profiling, molecular diagnostics, and precision…
Pharma Contract Research Organization (CRO) Services Market to Reach USD 193.7 B …
Introduction
The pharmaceutical industry is undergoing a rapid transformation as companies seek to accelerate drug development, reduce costs, and navigate increasingly complex regulatory landscapes. Contract Research Organizations (CROs) have become essential partners, offering specialized expertise in clinical trials, preclinical research, regulatory consulting, and data management.
With rising demand for innovative therapies, biologics, biosimilars, and personalized medicine, outsourcing to CROs is becoming a strategic necessity. These organizations not only provide cost-effective solutions but…
Neuroendocrine Breast Tumor Market to Reach USD 1.53 Billion by 2034, Growing at …
Introduction
Neuroendocrine breast tumors (NETs) are a rare and heterogeneous group of breast cancers characterized by neuroendocrine differentiation. Although they account for a small percentage of all breast cancers, their clinical significance is increasing due to improved diagnostic awareness and evolving treatment approaches.
Historically, limited research and lack of standardized diagnostic criteria slowed therapeutic progress. However, recent advances in imaging technologies, molecular profiling, and oncology research are improving detection rates and shaping…
Fc and Glycoengineered Antibodies Market to Reach USD 88.4 Billion by 2034, Lead …
Monoclonal antibodies (mAbs) have become a cornerstone of modern medicine, particularly in oncology, autoimmune diseases, and infectious diseases. However, traditional antibodies often face limitations such as reduced efficacy, immunogenicity, and shorter half-lives. To address these challenges, Fc and glycoengineering technologies are revolutionizing antibody development by modifying the Fc (fragment crystallizable) region and glycosylation patterns.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72689
These innovations enhance antibody-dependent cellular cytotoxicity (ADCC), increase…
Cutaneous Lupus Market to Reach USD 4.1 Billion by 2034, Growing at 8.0% CAGR
Introduction
Cutaneous lupus erythematosus (CLE) is a chronic autoimmune disorder primarily affecting the skin, leading to rashes, lesions, photosensitivity, and long-term scarring. While not as life-threatening as systemic lupus erythematosus (SLE), CLE has significant implications for patient quality of life, particularly due to its visibility and the social stigma associated with chronic skin disorders.
Historically, treatment options were limited to corticosteroids and antimalarials. However, with advances in immunology and biologics, new targeted…
Bronchial Spasm Market to Reach USD 34.9 Billion by 2034, Key Players: GlaxoSmit …
Bronchial spasm, also known as bronchospasm, is a sudden constriction of the muscles in the walls of the bronchioles, leading to narrowed airways, wheezing, coughing, and breathing difficulties. It is a hallmark symptom of conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and allergic reactions. The rising prevalence of respiratory disorders worldwide, coupled with exposure to environmental pollutants, allergens, and smoking, has significantly increased the demand for effective…
Respiratory Syncytial Virus (RSV) Market to Reach USD 12.7 Billion by 2034, Grow …
Introduction
Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections, particularly in infants, young children, and the elderly. Despite being a common seasonal virus, RSV poses serious risks for vulnerable populations, driving hospitalizations and significant healthcare costs.
Until recently, the lack of preventive and therapeutic options left healthcare providers reliant on supportive care and a few monoclonal antibody-based treatments. However, the approval of RSV vaccines for older adults…
Eye tracking in healthcare market Forecast 2025-2033 | Future Growth, Share & In …
Eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.
DataM Intelligence unveils its latest report on the "Eye Tracking in Healthcare Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and…
Erythropoietic Protoporphyria (EPP) Market Outlook : Expanding Awareness, Emergi …
Introduction
Erythropoietic Protoporphyria (EPP) is a rare genetic disorder characterized by extreme sensitivity to sunlight and certain artificial light sources. Patients experience severe pain, burning, and skin swelling after brief sun exposure, significantly impacting quality of life. For many years, treatment options were limited, and management largely involved avoidance strategies.
Today, the EPP market is evolving with new therapeutic innovations, increased awareness of rare diseases, and support from regulatory bodies. Advancements in…
Porphyria Targeting Therapies Market to Reach USD 11.1 Billion by 2034, Key Play …
Porphyrias are a group of rare inherited metabolic disorders caused by enzyme deficiencies in the heme biosynthesis pathway. These disorders lead to the accumulation of toxic porphyrins or their precursors, resulting in a wide range of symptoms including abdominal pain, neurological complications, skin sensitivity, and in some cases, life-threatening acute attacks.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72853
Despite being rare, porphyrias are gaining attention due to advancements in…
mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~ …
Introduction
Messenger RNA (mRNA) has emerged as a transformative tool in modern medicine, powering breakthrough vaccines and advancing the future of gene-based therapies. The success of mRNA-based COVID-19 vaccines showcased the potential of this technology and accelerated global investment into mRNA research, synthesis, and scalable manufacturing.
Beyond infectious diseases, mRNA therapies are being actively explored for oncology, rare genetic disorders, autoimmune diseases, and personalized medicine. As a result, the global mRNA synthesis…
Rising Demand for Personalized Nutrition Drives Diabetes Nutrition Market Expans …
London, UK - September 2025 | Strategic Revenue Insights Inc. The Diabetes Nutrition Market has emerged as a critical segment within the global healthcare and nutrition industry, reflecting a growing consumer focus on specialized dietary solutions. Valued for its pivotal role in managing diabetes, this market not only addresses the dietary needs of millions worldwide but also represents a rapidly expanding economic opportunity. As healthcare awareness rises, nutrition-based interventions…
DNA Damage Response (DDR) Market to Reach USD 26.8 Billion by 2034, Led by Astra …
DNA damage is a daily occurrence in human cells, caused by internal metabolic processes or external factors such as radiation, chemicals, and environmental stress. The DNA damage response (DDR) pathway is a critical cellular mechanism that detects and repairs DNA lesions, preserving genomic stability. Malfunctions in DDR pathways often lead to cancer, neurodegenerative conditions, and other diseases.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72855
The discovery of DDR inhibitors,…
Peanut Hypersensitivity Market to Hit USD 4.7 Billion by 2034, Growing at 12.8% …
Introduction
Peanut hypersensitivity, one of the most severe and potentially life-threatening food allergies, has become a growing public health concern worldwide. Affecting both children and adults, peanut allergies are among the leading causes of anaphylaxis and impose significant burdens on patients, caregivers, and healthcare systems.
For decades, management was limited to allergen avoidance and emergency interventions with epinephrine. However, recent advances in immunotherapy, biologics, and diagnostic tools are reshaping the treatment landscape.…
The market for non-small cell lung cancer (NSCLC) is expected to reach USD 79.1 …
Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for nearly 85% of all lung cancer cases. NSCLC is highly heterogeneous, comprising adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Historically treated with chemotherapy and radiation, NSCLC therapy has been revolutionized by targeted therapies and immunotherapies, which have improved survival rates and quality of life for patients.
Download Full PDF Sample Copy of…
Healthcare Contract Manufacturing Market to Reach USD 610.9 Billion by 2035, Dri …
The global Healthcare Contract Manufacturing Market is projected to grow from USD 193.2 billion in 2025 to USD 610.9 billion by 2035, expanding at a CAGR of 12.2% during the forecast period.
Growth is powered by rising pharmaceutical outsourcing, the surge in biologics and personalized medicine, and manufacturers' increasing reliance on CMOs (Contract Manufacturing Organizations) to cut costs and streamline operations.
MarketGenics identifies healthcare contract manufacturing as a strategic enabler for…
Herceptin Biosimilars Market to Reach USD 12.1 Billion by 2034, Growing at 11.2% …
Introduction
Breast cancer remains one of the most prevalent cancers worldwide, and the introduction of targeted therapies such as Herceptin (trastuzumab) has transformed treatment outcomes for patients with HER2-positive breast cancer. However, the high cost of biologics has limited accessibility, especially in low- and middle-income countries. The emergence of Herceptin biosimilars has dramatically changed this scenario by offering cost-effective alternatives without compromising efficacy and safety.
As global healthcare systems focus on reducing…
Novel T-Cell Immunotherapy Market to Reach USD 57.2 Billion by 2034 at 20.6% CAG …
Immunotherapy has transformed cancer treatment, and among the most groundbreaking approaches is T-cell immunotherapy. Unlike conventional therapies that target cancer cells directly, T-cell immunotherapies harness and reprogram a patient's own immune system to recognize and destroy tumors. Emerging modalities such as CAR-T (chimeric antigen receptor T-cell) therapies, TCR (T-cell receptor) therapies, tumor-infiltrating lymphocyte (TIL) therapies, and next-generation allogeneic T-cell approaches are reshaping oncology and rare disease management.
Download Full PDF Sample…
Hypoactive Sexual Desire Disorder Market to Reach USD 9.3 Billion by 2034, Growi …
Introduction
Hypoactive Sexual Desire Disorder (HSDD) is one of the most prevalent sexual dysfunction conditions among women, characterized by a persistent lack of sexual desire that causes personal distress. For decades, HSDD remained underdiagnosed and undertreated due to stigma and limited treatment options. However, in recent years, awareness campaigns, changing social attitudes, and advances in women's healthcare have transformed the way the condition is addressed.
Pharmaceutical innovations, coupled with digital therapy platforms,…
CRISPR Gene Editing Therapies Market to Hit USD 18.9 Billion by 2034 | CRISPR Th …
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has transformed the field of genetic medicine, offering unprecedented precision and efficiency in editing DNA. By enabling scientists to cut, modify, or replace faulty genes, CRISPR opens the door to treating genetic disorders, cancers, infectious diseases, and even enabling agricultural innovation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72861
In the therapeutic landscape, CRISPR-based interventions are gaining traction across rare diseases such…
Concussion Market to Reach USD 11.9 Billion by 2034, Growing at 4.8% CAGR
Introduction
Concussions, a form of mild traumatic brain injury (mTBI), are increasingly recognized as a major public health issue. Once overlooked or misdiagnosed, they are now understood to have long-term neurological consequences if untreated. Growing awareness, combined with advances in imaging, biomarkers, digital health tools, and rehabilitation, has positioned the concussion market for sustained growth.
The surge in sports-related injuries, road accidents, workplace trauma, and military-related head injuries has created significant demand…
Compression Stockings For Pregnancy Market Expansion Driven by Technology and Su …
The global Compression Stockings For Pregnancy market is witnessing remarkable growth, reflecting the increasing awareness of maternal health and the rising prevalence of pregnancy-related venous disorders. With a projected valuation of approximately $1.2 billion by 2033 and a CAGR of 6.5% between 2025 and 2033, this market has become a pivotal segment of the healthcare industry. Pregnant women worldwide are increasingly adopting compression stockings to prevent leg swelling, varicose veins,…
Go To Page 11350 11349 11348 11347 11346 11345 11344 11343 11342 11341 10620 10619 10618 10617 10616 10615 10614 10613 10612 10611
